Onconova Therapeutics Stock News

NEWTOWN, Pa., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a biopharmaceutical company focused on discovering and developing novel products for patien

NEWTOWN, Pa., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a biopharmaceutical company focused on discovering and developing novel products to treat c

NEWTOWN, Pa., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a biopharmaceutical company focused on discovering and developing novel products to treat c

The stock price of Onconova Therapeutics Inc (NASDAQ: ONTX) has increased by 25% today. This is why it happened.

NEWTOWN, Pa., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a biopharmaceutical company focused on discovering and developing novel products to treat c

Onconova Therapeutics (ONTX) stock is on the move Tuesday with heavy trading despite a lack of recent news from the company. The post Onconova Therapeutics: 7 Things for ONTX Stock Investors to Know A

NEWTOWN, Pa., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a biopharmaceutical company focused on discovering and developing novel products to treat cancer, today anno

Onconova Therapeutics, Inc. (ONTX) CEO Steve Fruchtman on Q3 2020 Results - Earnings Call Transcript

Conference call begins at 4:30 p.m. ET today

Company to host conference call and webcast at 4:30 p.m. Eastern Time on Thursday, November 12 Company to host conference call and webcast at 4:30 p.m. Eastern Time on Thursday, November 12

What is a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicator

Onconova Therapeutics, Inc. (NASDAQ:ONTX) Q2 2020 Earnings Conference Call Aug 12, 2020 4:30 PM ET Company Participants Avi Oler - Vice President, Corporate Development and General Counsel Steve Fruch

Shares of Onconova Therapeutics (NASDAQ:ONTX) decreased 1.89% in after-market trading after the company reported Q2 results.Quarterly Results Earnings per share rose 93.33% over the past year to ($0.0

* INSPIRE Phase 3 trial survival events reached * Topline data anticipated Q3-2020Conference call and webcast scheduled today, August 12, at 4:30 p.m. ETNEWTOWN, Pa., Aug. 12, 2020 (GLOBE NEWSWIRE) -

Company to host conference call and webcast at 4:30 p.m. Eastern Time on Wednesday, August 12NEWTOWN, Pa., Aug. 07, 2020 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage